Skip to main content

Table 1 Characteristics of the study cohort and number of cancers and cancer deaths by gender. Table shows mean (SD), percent or number (percent) for cancer outcomes

From: A prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health Study

Characteristic

Men (n = 1564)

Women (n = 1769)

p-value

Hb (g/dL)

151.4 (9.6)

135.5 (8.7)

<  0.001

MCV (fL)

89.0 (3.6)

89.1 (3.7)

0.225

MCH (pg/cell)

30.6 (1.3)

30.5 (1.4)

0.152

MCHC (g/dL)

34.4 (0.5)

34.3 (0.5)

<  0.001

RCDW

0.13 (0.01)

0.13 (0.01)

0.014

SF (μg/L)

228 (211)

101 (105)

 

Log SF

5.17 (0.73)

4.33 (0.73)

<  0.001

Serum iron (μmol/L)

19.0 (5.6)

17.9 (5.7)

 

Log serum iron

2.90 (0.30)

2.83 (0.33)

<  0.001

TS (%)

30.2 (10.5)

27.0 (13.9)

 

Log TS

3.35 (0.34)

3.23 (0.36)

<  0.001

Age (years)

50.7 (14.4)

51.9 (15.1)

0.022

Smoking status

 Never

41.6

58.5

<  0.001

 Ex

41.8

30.0

 

 Current

16.6

11.6

 

Alcohol consumption Never

3.3

8.2

<  0.001

 Ex

6.4

11.6

 

 Light

48.5

67.2

 

 Moderate/Heavy

39.1

8.6

 

 Unknown

2.7

4.4

 

Menopausal status  Pre/OC No

–

31.4

–

 Pre/OC Yes

–

11.6

 

 Post/HRT No

–

38.4

 

 Post/HRT Yes

–

18.5

 

Use of iron supplement

0.6

4.7

<  0.001

History of blood donation

34.6

28.9

<  0.001

Body mass index (kg/m2)

26.7 (3.3)

25.9 (4.7)

<  0.001

Waist circumference (cm)

93.6 (9.9)

81.2 (11.8)

<  0.001

Systolic blood pressure (mm Hg)

127 (15)

122 (18)

<  0.001

Diastolic blood pressure (mm Hg)

78 (10)

73 (10)

<  0.001

High density lipoprotein chol (mmol/L)

1.21 (0.30)

1.54 (0.39)

<  0.001

Triglycerides (mmol/L)

1.47 (1.06)

1.21 (0.75)

 

Log Triglycerides

0.21 (0.56)

0.05 (0.52)

<  0.001

Glucose, mmol/L

5.13 (1.43)

4.90 (1.22)

 

Log Glucose

1.61 (0.18)

1.57 (0.17)

<  0.001

HOMA-IR

1.90 (5.11)

1.67 (2.13)

 

log HOMA-IR

0.33 (0.68)

0.24 (0.65)

<  0.001

ALT (IU/L)

28.2 (16.3)

19.3 (10.6)

 

Log ALT

3.23 (0.45)

2.86 (0.41)

<  0.001

GGT (IU/L)

31.0 (23.8)

21.8 (17.2)

 

Log GGT

3.27 (0.53)

2.93 (0.50)

<  0.001

Bilirubin (μmol/L)

11.2 (5.3)

9.0 (3.8)

<  0.001

Albumin (g/L)

45.9 (2.7)

44.7 (2.6)

<  0.001

C-RP (mg/L)

2.69 (7.30)

3.62 (10.08)

 

log C-RP

0.26 (1.18)

0.54 (1.22)

<  0.001

Cancer outcomes

 Non-skin cancer death

94 (6.0)

97 (5.5)

0.514

 Non-skin cancer

304 (19.4)

284 (16.1)

0.011

 Prostate cancer

129 (8.2)

–

–

 Breast cancer

–

92 (5.2)

–

 Colorectal cancer

42 (2.7)

46 (2.6)

0.878

  1. OC (oral contraceptives), HRT (hormone replacement therapy), HOMA-IR (Homeostasis Model Assessment – estimated insulin resistance), ALT (alanine transaminase), GGT (gamma-glutamyltransferase), C-RP (C-reactive protein)